SB/Bristol Avandia Co-Promotion Unveiled Following Cmte. Recommendation

The Avandia co-promotion agreement between SmithKline Beecham and Bristol-Myers Squibb in the U.S. draws on Bristol's market knowledge in the diabetes field and the complex synergy of Bristol's Glucophage and the new SB agent.